Foundry Partners, LLC Natera, Inc. Transaction History

Foundry Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$30.32 - $91.33 $103,694 - $312,348	-3,420 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$86.26 - $119.0 $23,721 - $32,725	275 Added 8.74%	3,420 $319,000
Q3 2021 Oct 14, 2021	BUY	$100.17 - $126.36 $315,034 - $397,402	3,145 New	3,145 $350,000
Q2 2021 Jul 23, 2021	SELL	$86.05 - $119.72 $2.06 Million - $2.86 Million	-23,918 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$91.47 - $124.36 $1.63 Million - $2.22 Million	-17,856 Reduced 42.74%	23,918 $2.43 Million
Q4 2020 Feb 04, 2021	SELL	$66.66 - $111.74 $614,605 - $1.03 Million	-9,220 Reduced 18.08%	41,774 $4.16 Million
Q3 2020 Oct 23, 2020	BUY	$45.89 - $72.67 $83,795 - $132,695	1,826 Added 3.71%	50,994 $3.68 Million
Q2 2020 Aug 03, 2020	BUY	$26.36 - $49.86 $37,563 - $71,050	1,425 Added 2.98%	49,168 $2.45 Million
Q1 2020 May 08, 2020	BUY	$17.27 - $40.17 $824,521 - $1.92 Million	47,743 New	47,743 $1.43 Million

527

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.